On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to pooled ZIKV testing. Additionally, on July 5th Grifols received licensure for their NAT ZIKV test for both individual and pooled donations.
Check out the Communication page for the complete details on the NAT ZIKV test or by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...